Hematologic parameters are not predictors of upgrading or treatment in a racially diverse prospective study of men with prostate cancer on active surveillance.
T Maxwell SheltonJacob W GreenbergJonathan L SilbersteinL Spencer KranePublished in: The aging male : the official journal of the International Society for the Study of the Aging Male (2020)
Despite their usefulness in many types of malignancy, NLR and PLR were not predictors of upgrading or treatment in men on AS for localized PCa in our cohort.